Based on the title (no abstract provided), the paper appears to describe a multiple-attention deep multimodal fusion network for diagnosing glaucoma and neurodegenerative diseases.

Low direct value for Parkinson's therapeutic discovery—may help in diagnostic/biomarker detection but lacks mechanistic, intervention, or translational therapeutic insights relevant to PD.